Lee Jeong Yoon, Oh Yu-Whan, Lim Do-Sun, Yu Cheol Woong, Park Jae Hyoung, Joo Hyung Joon, Yong Hwan Seok, Kang Eun-Young, Kim Cherry, Lee Ki Yeol, Hwang Sung Ho
Department of Radiology (J.Y.L., Y.W.O., S.H.H.) and Division of Cardiology, Department of Internal Medicine (D.S.L., C.W.Y., J.H.P., H.J.J.), Korea University Anam Hospital, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, Republic of Korea; Department of Radiology, Korea University Guro Hospital, Seoul, Republic of Korea (H.S.Y., E.Y.K.); and Department of Radiology, Korea University Ansan Hospital, Ansan, Republic of Korea (C.K., K.Y.L.).
Radiol Cardiothorac Imaging. 2020 Aug 20;2(4):e190203. doi: 10.1148/ryct.2020190203. eCollection 2020 Aug.
To evaluate the feasibility of coronary iodine concentration (CIC) by using spectral CT in the assessment of the outcome of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO).
In total, 50 consecutive patients underwent preprocedural coronary CT angiography with spectral CT prior to their staged PCI for CTO between June 2017 and July 2018. Iodine density maps, referred to as iodine-no-water maps throughout, with spectral CT provided the CIC at proximal CTO (CTO-CIC). Depending on the outcome of PCI, all CTO lesions were divided into two groups: failed PCI and successful PCI. The receiver operating characteristic curve was used to determine the cutoff values of CTO-CIC in the assessment of the outcome of PCI for CTO.
Of the 50 CTO lesions in 50 patients, 34 (68%) and 16 (32%) were assigned to the successful PCI and failed PCI groups, respectively. The mean CTO-CIC was significantly less in the failed PCI group than in the successful PCI group (1.3 mg/mL ± 0.9 [standard deviation] vs 5.2 mg/mL ± 2.5; < .001). A low CTO-CIC (≤ 2.5 mg/mL) predicted failed PCI with 87% sensitivity, 79% specificity, 79% positive predictive value, and 90% negative predictive value. At multivariable analysis, the low CTO-CIC was significantly associated with the failed PCI (odds ratio, 27.0; 95% confidence interval: 4.9, 147.6; < .0001).
The CTO-CIC determined by using spectral CT may be useful in the assessment of the outcome of staged PCI for CTO.See also the commentary by Rubinshtein and Blankstein in this issue.© RSNA, 2020.
评估使用光谱CT测量冠状动脉碘浓度(CIC)在评估慢性完全闭塞(CTO)患者经皮冠状动脉介入治疗(PCI)结局中的可行性。
2017年6月至2018年7月期间,共有50例连续患者在分期CTO-PCI术前接受了光谱CT冠状动脉CT血管造影检查。光谱CT生成的碘密度图(全程称为无水碘图)提供了CTO近端的CIC(CTO-CIC)。根据PCI结局,所有CTO病变分为两组:PCI失败组和PCI成功组。采用受试者操作特征曲线确定CTO-CIC在评估CTO-PCI结局中的截断值。
50例患者的50处CTO病变中,分别有34处(68%)和16处(32%)被归入PCI成功组和PCI失败组。PCI失败组的平均CTO-CIC显著低于PCI成功组(1.3 mg/mL±0.9[标准差] vs 5.2 mg/mL±2.5;P<0.001)。低CTO-CIC(≤2.5 mg/mL)预测PCI失败的敏感度为87%、特异度为79%、阳性预测值为79%、阴性预测值为90%。多变量分析显示,低CTO-CIC与PCI失败显著相关(比值比,27.0;95%置信区间:4.9,147.6;P<0.0001)。
使用光谱CT测定的CTO-CIC可能有助于评估分期CTO-PCI的结局。另见本期Rubinshtein和Blankstein的评论。©RSNA,2020。